Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA’s Nonprescription Office Adds Executive Posts To Fulfill “Safety First”

This article was originally published in The Tan Sheet

Executive Summary

FDA's office with oversight of over-the-counter drugs is adding executive positions as part of the agency's "Safety First" initiative

You may also be interested in...

FDA Sheds Cumbersome Hiring Process To Beef Up Scientific Capabilities

FDA is launching a recruitment blitz to fill more than 1,300 staff positions following an Office of Personnel Management decision to give the agency direct-hire authority, which allows it to bypass certain Department of Health and Human Services rating and ranking procedures when assessing applicants

FDA “Safety First” Initiative, Agency’s Requests Draw Doubts From DeLauro

FDA is implementing the Safety First initiative to "ensure that significant post-market safety issues are our highest priority," according to acting Center for Drug Evaluation and Research Director Janet Woodcock

People In Brief

Perrigo promotes in pricing, planning





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts